Cargando…
Forecasting Individual Patients’ Best Time for Surgery in Colon-Rectal Cancer by Tumor Regression during and after Neoadjuvant Radiochemotherapy
The standard treatment of locally advanced rectal cancer is neoadjuvant chemoradiotherapy before surgery. For those patients experiencing a complete clinical response after the treatment, a watch-and-wait strategy with close monitoring may be practicable. In this respect, the identification of bioma...
Autores principales: | Martorana, Emanuele, Castorina, Paolo, Ferini, Gianluca, Forte, Stefano, Mare, Marzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220791/ https://www.ncbi.nlm.nih.gov/pubmed/37241020 http://dx.doi.org/10.3390/jpm13050851 |
Ejemplares similares
-
Tumor Volume Regression during and after Radiochemotherapy: A Macroscopic Description
por: Castorina, Paolo, et al.
Publicado: (2022) -
Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
por: Spolverato, Gaya, et al.
Publicado: (2011) -
Dynamical Synergy of Drug Combinations during Cancer Chemotherapy
por: Castorina, Paolo, et al.
Publicado: (2022) -
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
por: Schiffmann, Leif, et al.
Publicado: (2013) -
Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI
por: Bostel, T., et al.
Publicado: (2020)